Non-invasive Diagnosis of Pleural Malignancies: The Role of Tumor Markers
Source: PubMed.com
Serum markers are an attempt to diagnose mesothelioma malignancies by analysis of a blood or other fluid test. This is a non-invasive procedure and discovering the efficacy of these diagnostic materials will be an important progression in our ability to diagnose mesothelioma. A study was recently completed that looked at the use of three different markers and their efficacy of diagnosis. It was found that Cyfra 21.1 was able to discriminate between healthy and malignant cells and that the combination of soluble mesothelin-related protein (SMRP) and carcino-embryonic antigen (CEA) was very effective for distinguishing between mesothelioma and non-small cell lung cancer.
More articles by Nancy Meredith
Nancy Meredith is a blog and web content writer with more than 20 years of professional experience in the Information Technology industry. She has been writing about Mesothelioma for 4 years. Follow Nancy on Google+
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.
Nancy is a blog writer with more than 20 years of professional experience in the Information Technology industry. She lives in Wake Forest, N.C.